These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 18162196

  • 1. Up-regulation of PPARgamma in myocardial infarction.
    Fliegner D, Westermann D, Riad A, Schubert C, Becher E, Fielitz J, Tschöpe C, Regitz-Zagrosek V.
    Eur J Heart Fail; 2008 Jan; 10(1):30-8. PubMed ID: 18162196
    [Abstract] [Full Text] [Related]

  • 2. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ, Shang QH, Jin HY, Song B, Oudit GY, Lu L, Zhou T, Xu YL, Gao PJ, Zhu DL, Penninger JM, Zhong JC.
    J Transl Med; 2013 Sep 25; 11():229. PubMed ID: 24067190
    [Abstract] [Full Text] [Related]

  • 3. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
    Jing L, Li WM, Zhou LJ, Li S, Kou JJ, Song J.
    Alcohol Clin Exp Res; 2008 Nov 25; 32(11):1999-2007. PubMed ID: 18783396
    [Abstract] [Full Text] [Related]

  • 4. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thöne-Reineke C, Unger T, Kintscher U.
    Hypertension; 2005 Jul 25; 46(1):137-43. PubMed ID: 15939809
    [Abstract] [Full Text] [Related]

  • 5. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
    Kusunoki H, Taniyama Y, Rakugi H, Morishita R.
    J Am Heart Assoc; 2013 Apr 22; 2(2):e000103. PubMed ID: 23608606
    [Abstract] [Full Text] [Related]

  • 6. Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells.
    Kobayashi T, Akiyama Y, Akiyama N, Katoh H, Yamamoto S, Funatsuki K, Yanagimoto T, Notoya M, Asakura K, Shinosaki T, Hanasaki K.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):23-8. PubMed ID: 20826135
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
    Watanabe R, Suzuki J, Wakayama K, Kumagai H, Ikeda Y, Akazawa H, Komuro I, Isobe M.
    Hypertens Res; 2016 Apr 15; 39(4):237-44. PubMed ID: 26657004
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
    Schupp M, Janke J, Clasen R, Unger T, Kintscher U.
    Circulation; 2004 May 04; 109(17):2054-7. PubMed ID: 15117841
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.
    Yu J, Zhao J, Liu W, Ge Z, Du Y.
    Heart Vessels; 2011 Nov 04; 26(6):646-53. PubMed ID: 21229253
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.
    Janke J, Schupp M, Engeli S, Gorzelniak K, Boschmann M, Sauma L, Nystrom FH, Jordan J, Luft FC, Sharma AM.
    J Hypertens; 2006 Sep 04; 24(9):1809-16. PubMed ID: 16915030
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.
    J Cardiovasc Pharmacol; 1999 Mar 04; 33(3):433-9. PubMed ID: 10069680
    [Abstract] [Full Text] [Related]

  • 12. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY, Huang YL, Sun YH.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 20; 85(15):1053-6. PubMed ID: 16029550
    [Abstract] [Full Text] [Related]

  • 13. Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia.
    Rong X, Li Y, Ebihara K, Zhao M, Kusakabe T, Tomita T, Murray M, Nakao K.
    Br J Pharmacol; 2010 Aug 20; 160(7):1796-807. PubMed ID: 20649581
    [Abstract] [Full Text] [Related]

  • 14. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
    Jugdutt BI, Menon V.
    Mol Cell Biochem; 2004 May 20; 260(1-2):111-8. PubMed ID: 15228092
    [Abstract] [Full Text] [Related]

  • 15. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
    Afzal S, Sattar MA, Johns EJ, Abdulla MH, Akhtar S, Hashmi F, Abdullah NA.
    J Physiol Biochem; 2016 Dec 20; 72(4):593-604. PubMed ID: 27405250
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity.
    Schupp M, Clemenz M, Gineste R, Witt H, Janke J, Helleboid S, Hennuyer N, Ruiz P, Unger T, Staels B, Kintscher U.
    Diabetes; 2005 Dec 20; 54(12):3442-52. PubMed ID: 16306360
    [Abstract] [Full Text] [Related]

  • 17. Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ.
    Takai S, Jin D, Miyazaki M.
    J Pharmacol Sci; 2011 Dec 20; 116(3):309-15. PubMed ID: 21691037
    [Abstract] [Full Text] [Related]

  • 18. AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.
    Nguyen QT, Colombo F, Clement R, Gosselin H, Rouleau JL, Calderone A.
    Br J Pharmacol; 2003 Apr 20; 138(8):1485-94. PubMed ID: 12721104
    [Abstract] [Full Text] [Related]

  • 19. Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats.
    Di Filippo C, Lampa E, Tufariello E, Petronella P, Freda F, Capuano A, D'Amico M.
    Obes Res; 2005 Nov 20; 13(11):1909-14. PubMed ID: 16339122
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI, Menon V.
    J Cardiovasc Pharmacol Ther; 2003 Sep 20; 8(3):217-26. PubMed ID: 14506547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.